Abstract
The solid organ transplantation is the best therapeutic option for patients with end-organ failures. However, this treatment risks infections and a range of side-effects, which, together with the inexorable chronic allograft injury, limit the graft and patient survival. These findings highlight the urgent need for more effective and less toxic treatments to improve the outcome of solid or…